1-4 of 4
Colby M. Chapman
Close
Sort by
Journal Articles

Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation

Patricia Pérez-Galán, Helena Mora-Jensen, Marc A. Weniger, Arthur L. Shaffer, III, Edgar G. Rizzatti, Colby M. Chapman, Clifton C. Mo, Lawrence S. Stennett, Christoph Rader, Poching Liu, Nalini Raghavachari, Maryalice Stetler-Stevenson, Constance Yuan, Stefania Pittaluga, Irina Maric, Kieron M. Dunleavy, Wyndham H. Wilson, Louis M. Staudt, Adrian Wiestner
Journal: Blood
Blood (2011) 117 (2): 542–552.
https://doi.org/10.1182/blood-2010-02-269514
Published: 2011
Includes: Supplemental data
Journal Articles

The PI3K Inhibitor ON 01910.Na Inhibits Critical Survival Pathways and Induces Apoptosis in CLL Cells through Induction of NOXA and BIM.

Patricia Perez Galan, PhD, Colby M Chapman, Federica Gibellini, PhD, Poching Liu, PhD, Nalini Raghavachari, PhD, Mark Roschewski, MD, Adrian Wiestner, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 412.
https://doi.org/10.1182/blood.V114.22.412.412
Published: 2009
Journal Articles

Bortezomib Resistance in Mantle Cell Lymphoma Is Associated with Expression of a Plasmacytoid Differentiation Program.

Patricia Perez Galan, PhD, Helena Mora Jensen, Marc A Weniger, PhD, Colby M Chapman, Poching Liu, PhD, Nalini Raghavachari, PhD, Arthur L Shaffer, III, PhD, Louis M. Staudt, MD, PhD, Adrian Wiestner, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 287.
https://doi.org/10.1182/blood.V114.22.287.287
Published: 2009
Journal Articles

Receptor Tyrosine Kinase-Like Orphan Receptor 1 (ROR-1) Is Expressed in Low Grade NHL and B-CLL and Activates the Non Canonical Wnt Pathway

Federica Gibellini, PhD, Colby M Chapman, BS, Yair Herishanu, MD, Berengere Vire, PhD, Keyvan Keyvanfar, Ndegwa Njuguna, MD, Adrian Wiestner, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3748.
https://doi.org/10.1182/blood.V112.11.3748.3748
Published: 2008